897 — Wai Yuen Tong Medicine Holdings Cashflow Statement
0.000.00%
- HK$371.28m
- HK$633.96m
- HK$783.88m
- 46
- 95
- 65
- 83
Annual cashflow statement for Wai Yuen Tong Medicine Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | HKAS | HKAS | HKAS | — | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 455 | -303 | -47.3 | -11.9 | — |
Depreciation | |||||
Non-Cash Items | -557 | 397 | 234 | 144 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -43.5 | 226 | -143 | -79 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -32.5 | 413 | 152 | 166 | — |
Capital Expenditures | -6.8 | -59.5 | -26 | -33.4 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 432 | -4.99 | 48.2 | 55.2 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 425 | -64.5 | 22.2 | 21.8 | — |
Financing Cash Flow Items | -45.1 | -84.4 | -115 | -97 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -81.6 | -351 | -204 | -159 | — |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 304 | 31.5 | 2.91 | 16.6 | — |